These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20649809)

  • 1. Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists.
    Regnier Denois V; Poirson J; Nourissat A; Jacquin JP; Guastalla JP; Chauvin F
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):520-7. PubMed ID: 20649809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors.
    Thivat E; Van Praagh I; Belliere A; Mouret-Reynier MA; Kwiatkowski F; Durando X; Mahammedi H; Dillies AF; Chollet P; Chevrier R
    Oncology; 2013; 84(2):67-74. PubMed ID: 23128040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive results achieved with new oral chemotherapy agent.
    Timmerman D
    Oncol Nurs Forum; 1999 May; 26(4):675. PubMed ID: 10337634
    [No Abstract]   [Full Text] [Related]  

  • 5. How the new oral antineoplastics affect nursing practice: capecitabine serves to illustrate.
    Szetela AB; Gibson DE
    Am J Nurs; 2007 Dec; 107(12):40-8; quiz 48-9. PubMed ID: 18049060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
    Yamamoto D; Iwase S; Kitamura K; Odagiri H; Yamamoto C; Nagumo Y
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):509-14. PubMed ID: 17516068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
    Figueiredo Junior AG; Forones NM
    Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancer.
    Favier L; Isambert N; Zanetta S; Ferrant E; Mayer F; Chauffert B; Fumoleau P; Garnier J; Biville F; Coudert B
    Breast; 2008 Feb; 17(1):36-41. PubMed ID: 17698359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic adherence to oral cancer therapy and interdisciplinary management].
    Jeanneret LA; Schneider MP; Troxler S; Bugnon O; Lüthi F
    Rev Med Suisse; 2011 May; 7(296):1154-8, 1160. PubMed ID: 21721207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?
    Górnaś M; Szczylik C
    Eur J Cancer Care (Engl); 2010 Jan; 19(1):131-6. PubMed ID: 19686351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer.
    Camacho FT; Wu J; Wei W; Kimmick G; Anderson RT; Balkrishnan R
    J Med Econ; 2009 Sep; 12(3):238-45. PubMed ID: 19732030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.
    Hennig IM; Naik JD; Brown S; Szubert A; Anthoney DA; Jackson DP; Melcher AM; Crawford SM; Bradley C; Brown JM; Seymour MT
    J Clin Oncol; 2008 Jul; 26(20):3411-7. PubMed ID: 18612156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
    Pentheroudakis G; Pappas P; Golfinopoulos V; Fountzilas G; Nikolaidou M; Boumba VA; Vougiouklakis T; Nikiforidis L; Tzamakou E; Siarabi O; Marselos M; Pavlidis N
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):733-9. PubMed ID: 17333194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer.
    Leonard R; Hennessy BT; Blum JL; O'Shaughnessy J
    Clin Breast Cancer; 2011 Dec; 11(6):349-56. PubMed ID: 21856245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer.
    Law CC; Fu YT; Chau KK; Choy TS; So PF; Wong KH
    Dis Colon Rectum; 2007 Dec; 50(12):2180-7. PubMed ID: 17963003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer.
    Susnjar S; Bosnjak S; Radulovic S; Stevanovic J; Gajic-Dobrosavljevic M; Kreacic M
    J BUON; 2007; 12(2):189-96. PubMed ID: 17600871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    Traina TA; Theodoulou M; Feigin K; Patil S; Tan KL; Edwards C; Dugan U; Norton L; Hudis C
    J Clin Oncol; 2008 Apr; 26(11):1797-802. PubMed ID: 18398145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
    Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.